Capital Market Strategies LLC Sells 102 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Capital Market Strategies LLC lowered its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 5.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,885 shares of the healthcare conglomerate’s stock after selling 102 shares during the period. Capital Market Strategies LLC’s holdings in UnitedHealth Group were worth $954,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently made changes to their positions in UNH. Hanlon Investment Management Inc. purchased a new position in UnitedHealth Group during the 2nd quarter valued at about $200,000. Parcion Private Wealth LLC grew its stake in shares of UnitedHealth Group by 22.6% during the second quarter. Parcion Private Wealth LLC now owns 1,500 shares of the healthcare conglomerate’s stock valued at $764,000 after buying an additional 277 shares during the last quarter. Norden Group LLC boosted its stake in shares of UnitedHealth Group by 15.6% during the second quarter. Norden Group LLC now owns 6,080 shares of the healthcare conglomerate’s stock valued at $3,097,000 after purchasing an additional 820 shares during the period. Umpqua Bank increased its position in shares of UnitedHealth Group by 3.5% in the second quarter. Umpqua Bank now owns 5,412 shares of the healthcare conglomerate’s stock valued at $2,756,000 after acquiring an additional 184 shares during the period. Finally, Strategic Financial Concepts LLC increased its stake in shares of UnitedHealth Group by 43,843.0% during the second quarter. Strategic Financial Concepts LLC now owns 232,019 shares of the healthcare conglomerate’s stock valued at $118,158,000 after buying an additional 231,491 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on UNH shares. Truist Financial lowered their target price on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday. HSBC cut UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, October 17th. KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday, October 11th. They set an “overweight” rating and a $675.00 target price on the stock. Oppenheimer lifted their price target on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, Cantor Fitzgerald upped their price target on shares of UnitedHealth Group from $591.00 to $644.00 and gave the company an “overweight” rating in a research note on Wednesday, October 16th. Three equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $627.58.

UnitedHealth Group Stock Up 0.8 %

UNH stock traded up $4.01 during trading on Monday, hitting $517.01. 1,857,763 shares of the company’s stock traded hands, compared to its average volume of 3,004,598. The firm has a market capitalization of $475.80 billion, a P/E ratio of 33.68, a PEG ratio of 1.53 and a beta of 0.62. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a fifty day simple moving average of $559.83 and a two-hundred day simple moving average of $561.31. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The firm had revenue of $100.82 billion during the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter last year, the firm earned $6.56 EPS. The business’s quarterly revenue was up 9.2% on a year-over-year basis. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.62%. The ex-dividend date was Monday, December 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.72%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.